Ignite Creation Date:
2025-12-24 @ 11:08 PM
Ignite Modification Date:
2026-01-02 @ 3:43 AM
Study NCT ID:
NCT06747169
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-12-27
First Post:
2024-12-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Sintilimab Combined with Nab-PP Plus Rh-endostatin in Locally Advanced/advanced and Recurrent Metastatic Squamous Non-small Cell Lung Cancer: a Single-arm, Multicenter Clinical Study
Sponsor:
Jian-Guo Zhou, MD, PhD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-12-17
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-12-17
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-17
Completion Date Type:
ESTIMATED
First Submit Date:
2024-12-14
First Submit QC Date:
None
Study First Post Date:
2024-12-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-20
Last Update Post Date:
2024-12-27
Last Update Post Date Type:
ACTUAL